These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1326932)

  • 1. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.
    Endoh T; Matsuura H; Tanaka C; Nagase H
    Arch Int Pharmacodyn Ther; 1992; 316():30-42. PubMed ID: 1326932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
    Wettstein JG; Grouhel A
    Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of the morphine-induced Straub tail reaction by kappa-opioid receptor activation in mice.
    Narita M; Suzuki T; Misawa M; Nagase H
    Psychopharmacology (Berl); 1993; 110(1-2):254-6. PubMed ID: 7870894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists.
    Portoghese PS; Lipkowski AW; Takemori AE
    Life Sci; 1987 Mar; 40(13):1287-92. PubMed ID: 2882399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys.
    Butelman ER; Negus SS; Ai Y; de Costa BR; Woods JH
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1269-76. PubMed ID: 8263790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test.
    Horan P; Taylor J; Yamamura HI; Porreca F
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1237-43. PubMed ID: 1312164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
    Ko MC; Johnson MD; Butelman ER; Willmont KJ; Mosberg HI; Woods JH
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1113-20. PubMed ID: 10565831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
    Takemori AE; Ho BY; Naeseth JS; Portoghese PS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):255-8. PubMed ID: 2839664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice.
    Song ZH; Takemori AE
    J Pharmacol Exp Ther; 1991 Mar; 256(3):909-12. PubMed ID: 1848633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
    Ko MC; Willmont KJ; Lee H; Flory GS; Woods JH
    Brain Res; 2003 Aug; 982(1):38-44. PubMed ID: 12915238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
    J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U-50488H, a selective kappa-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice.
    Hiramatsu M; Hyodo T; Kameyama T
    Eur J Pharmacol; 1996 Nov; 315(2):119-25. PubMed ID: 8960874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers.
    Pruhs RJ; Peña RT; Quock RM
    Life Sci; 2007 Apr; 80(19):1816-20. PubMed ID: 17379253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.
    Patkar KA; Wu J; Ganno ML; Singh HD; Ross NC; Rasakham K; Toll L; McLaughlin JP
    J Pharmacol Exp Ther; 2013 Sep; 346(3):545-54. PubMed ID: 23853171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
    Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1021-7. PubMed ID: 7680715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone in vivo protects mu receptors from inactivation by beta-funaltrexamine, but not kappa receptors from inactivation by nor-binaltorphimine.
    Paronis CA; Waddell AB; Holtzman SG
    Pharmacol Biochem Behav; 1993 Dec; 46(4):813-7. PubMed ID: 8309960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine.
    Suzuki T; Narita M; Takahashi Y; Misawa M; Nagase H
    Eur J Pharmacol; 1992 Mar; 213(1):91-7. PubMed ID: 1499660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.